US Edition
Respiratory Syncytial Virus Vaccination
3 Articles
3 Articles
Authority called the parents to request the dose promptly. 639 infants from the region, born since October 1, 2024, are at risk of suffering the consequences of the Sincicial Virus, which in case of complications can even result in a fatal outcome. It made it known... The post 639 infants from 2024 are at risk for the syncicial virus appeared first on Thermometer News.
Survival of recombinant monoclonal and naturally-occurring human milk immunoglobulins A and G specific to respiratory syncytial virus F protein across simulated human infant gastrointestinal digestion
To help rationally design an antibody for oral administration, we examined how different isotypes (IgG, IgA and sIgA) with the same variable sequence …
Respiratory Syncytial Virus Vaccination
To the Editor The Research Letter by Dr Karaba and colleagues, “Antibody Response to Respiratory Syncytial Virus Vaccination in Immunocompromised Persons,” provides interesting real-world data on the effectiveness of the respiratory syncytial virus (RSV) vaccine in patients with self-reported immunocompromising conditions from a prospective national cohort. The heterogeneity and low immunogenicity response to the vaccine are noteworthy, as 40% o…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
